News
BBLG
1.825
+3.11%
0.055
Weekly Report: what happened at BBLG last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at BBLG last week (1117-1121)?
Weekly Report · 11/24 10:15
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation
Benzinga · 11/17 17:05
Weekly Report: what happened at BBLG last week (1110-1114)?
Weekly Report · 11/17 10:15
Weekly Report: what happened at BBLG last week (1103-1107)?
Weekly Report · 11/10 10:13
Weekly Report: what happened at BBLG last week (1027-1031)?
Weekly Report · 11/03 10:14
Weekly Report: what happened at BBLG last week (1020-1024)?
Weekly Report · 10/27 10:16
Weekly Report: what happened at BBLG last week (1013-1017)?
Weekly Report · 10/20 10:13
Weekly Report: what happened at BBLG last week (1006-1010)?
Weekly Report · 10/13 10:16
Weekly Report: what happened at BBLG last week (0929-1003)?
Weekly Report · 10/06 10:12
Weekly Report: what happened at BBLG last week (0922-0926)?
Weekly Report · 09/29 10:13
Weekly Report: what happened at BBLG last week (0915-0919)?
Weekly Report · 09/22 10:14
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 09/17 21:06
Weekly Report: what happened at BBLG last week (0908-0912)?
Weekly Report · 09/15 09:54
Weekly Report: what happened at BBLG last week (0901-0905)?
Weekly Report · 09/08 09:55
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 09/05 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/04 17:05
Bone Biologics Shares Rise After Positive Cash, NB1 Updates
Dow Jones · 09/04 16:51
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/04 12:08
Bone Biologics CEO Issues Stockholder Letter Highlighting NB1 Clinical Progress, Product Improvements, Year-End Enrollment Goal, Expanded Shelf Life, Interim Trial Update, And 2026 Financial Outlook
Benzinga · 09/04 11:08
More
Webull provides a variety of real-time BBLG stock news. You can receive the latest news about Bone Biologics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BBLG
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.